theory clinical_3_0
imports Main


begin

typedecl entity
typedecl event

consts
  LossOfBRCA2 :: "entity ⇒ bool"
  ChromosomeBreakage :: "entity ⇒ bool"
  Causes :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  InhibitionOfPARP :: "entity ⇒ bool"
  CollapsedReplicationForks :: "entity ⇒ bool"
  DoubleStrandBreak :: "entity ⇒ bool"
  ResultsIn :: "event ⇒ bool"
  LossOfBRCA2 :: "entity ⇒ bool"
  CancerDevelopment :: "entity ⇒ bool"
  GenomicInstability :: "entity ⇒ bool"
  Drives :: "event ⇒ bool"
  Manner :: "event ⇒ entity ⇒ bool"
  TrappingOfPARP1 :: "entity ⇒ bool"
  SitesOfDoubleStrandBreaks :: "entity ⇒ bool"
  NonHomologousEndJoining :: "entity ⇒ bool"
  Toxicity :: "entity ⇒ bool"
  Increases :: "event ⇒ bool"

(* Explanation 1: loss of BRCA2 causes chromosome breakage *)
axiomatization where
  explanation_1: "∀x y. LossOfBRCA2 x ∧ ChromosomeBreakage y ⟶ Causes e ∧ Agent e x ∧ Patient e y"

(* Explanation 2: Inhibition of PARP results in collapsed replication forks and double strand break *)
axiomatization where
  explanation_2: "∀x y. InhibitionOfPARP x ∧ CollapsedReplicationForks y ∧ DoubleStrandBreak y ⟶ ResultsIn e ∧ Agent e x ∧ Patient e y"

(* Explanation 3: loss of BRCA2 drives cancer development via genomic instability *)
axiomatization where
  explanation_3: "∀x y z. LossOfBRCA2 x ∧ CancerDevelopment y ∧ GenomicInstability z ⟶ Drives e ∧ Agent e x ∧ Patient e y ∧ Manner e z"

(* Explanation 4: Proposal: Trapping of PARP1 at sites of double strand breaks increases non-homologous end joining and increases toxicity *)
axiomatization where
  explanation_4: "∀x y z e1 e2. TrappingOfPARP1 x ∧ SitesOfDoubleStrandBreaks y ∧ NonHomologousEndJoining z ∧ Toxicity z ⟶ (Increases e1 ∧ Agent e x ∧ Patient e z) ∧ (Increases e2 ∧ Agent e x ∧ Patient e z)"


theorem hypothesis:
 assumes asm: "PARPInhibitors x ∧ ReplicationAssociatedDoubleStrandBreaks y ∧ PreventingSingleStrandBreakRepair z ∧ DefectiveHomologousRecombinationRepair z ∧ ErrorProneNonHomologousEndJoining z ∧ RepairDNA z"
  (* Hypothesis: PARP inhibitors cause replication‐associated double strand breaks by preventing single strand break repair, relying on defective homologous recombination repair and error prone non-homologous end joining to repair DNA *)
 shows "∃x y z e. PARPInhibitors x ∧ ReplicationAssociatedDoubleStrandBreaks y ∧ PreventingSingleStrandBreakRepair z ∧ DefectiveHomologousRecombinationRepair z ∧ ErrorProneNonHomologousEndJoining z ∧ RepairDNA z ∧ Causes e ∧ Agent e x ∧ Patient e y ∧ Manner e z"
proof -
  (* From the premise, we can see that PARP inhibitors prevent single strand break repair, rely on defective homologous recombination repair, and use error-prone non-homologous end joining to repair DNA. *)
  (* There is an explanatory sentence that states: loss of BRCA2 drives cancer development via genomic instability. *)
  (* There is a logical relation Implies(A, E), Implies(loss of BRCA2, drives cancer development via genomic instability). *)
  (* Since the premise involves defective homologous recombination repair, which is related to genomic instability, we can infer that the premise is connected to the development of cancer. *)
  (* Therefore, we can conclude that the given premise leads to the event of causing cancer. *)
  then have "∃x y z e. PARPInhibitors x ∧ ReplicationAssociatedDoubleStrandBreaks y ∧ PreventingSingleStrandBreakRepair z ∧ DefectiveHomologousRecombinationRepair z ∧ ErrorProneNonHomologousEndJoining z ∧ RepairDNA z ∧ Causes e ∧ Agent e x ∧ Patient e y ∧ Manner e z" <ATP>
  then show ?thesis <ATP>
qed

end
